Labiotech.eu

Better Juice Launches Commercial Sugar Reduction Plant 002

More News! 9 Nov 2022

Better Juice launches naturally converting fruit juice sugars to prebiotics

A new site housing technology to naturally turn the composition of fruit juice sugars including sucrose, glucose and fructose into better-for-you prebiotics has been opened by Better Juice Ltd. The Israeli sugar-reduction startup launched its first full-capacity manufacturing plant for full commercial production of sugar-reducing immobilized enzymes. The new facility, the company says, will allow […]

November 9, 2022 - 4 minutesmins - By Liza Laws

More News! 9 Nov 2022

Wyss Center’s ABILITY system to improve quality of life for people with severe paralysis

The Wyss Center for Bio and Neuroengineering has shared the latest signals recorded by its fully plantable ABILITY brain computer interface (BCI) at a Society for Neuroscience meeting. ABILITY is designed to improve quality of life and independence for people with severe paralysis and demonstrates safety and efficacy in pre-clinial trials. New details of the […]

November 9, 2022 - 3 minutesmins - By Liza Laws

More News! 9 Nov 2022

Sensorium closes $30M deal to advance drug discovery engine

Sensorium Therapeutics, announced the closing of a $30 million series a financing to advance its initial asset, SENS-01, and Biodynamic Discovery Platform (BDP). The platform is a drug discovery engine that rapidly identifies, synthesizes, and enhances targeted molecules as therapeutics. The round was led by Santé Ventures, a specialized healthcare and life sciences investment firm […]

November 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Nov 2022

GHO Capital and Vistria Group to acquire CDMO Alcami

Global Healthcare Opportunities, (GHO Capital Partners LLP), and The Vistria Group, have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation, a pharmaceutical contract development and manufacturing organization (CDMO), from funds affiliated with Madison Dearborn Partners (MDP) and Ampersand Capital Partners. Headquartered in North Carolina, Alcami is involved in drug product […]

November 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

Does covid vaccination boost cancer treatment?

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. It was feared that vaccination against Covid-19 could reduce the success of cancer treatment or cause severe side effects. However, a recent study by the universities of Bonn, Germany, and Shanxi, China, say this isn’t the case. According […]

November 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

Google and Meta AI could boost cancer research and drug discovery

Encoded in the DNA, a protein may be represented as a thread of hundreds of individual molecules called amino acids, linked together. Depending on the particular amino acids combination, a protein folds in a particular way, resulting in a functional 3D shape. The shape makes the function, and with 20 different amino acids available, the […]

November 8, 2022 - 3 minutesmins - By Jim Cornall

More News! 8 Nov 2022

JelloX Biotech helps doctors diagnose and treat cancer tumors with speed and accuracy

Taiwan-based start-up, JelloX Biotech, says its products will help doctors diagnose and treat cancer tumors with speed and accuracy without an added strain on budgets. The company made its debut at Intel Innovation in September. JelloX has gained the attention of healthcare experts and pharmaceutical brands for its potential for the future of cancer pathology using […]

November 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Nov 2022

Vir Biotech presents new data for functional cure of chronic Hep B virus

Vir Biotechnology, Inc. today (November 8) announced new data from its robust hepatitis B virus (HBV) portfolio aimed at achieving a functional cure. These data, plus health outcomes research, are being presented at the American Association for the Study of Liver Diseases (AASLD). The Liver Meeting was delivered in two oral presentations, both of which were selected […]

November 8, 2022 - 3 minutesmins - By Liza Laws

More News! 8 Nov 2022

ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy

ISA Pharmaceuticals B.V, a Netherlands-based clinical stage biotech developing immunotherapies to treat cancers and infectious diseases has had a phase 1 clinical study published. The study, using ISA Pharmaceuticals’ Amplivant adjuvant and synthetic long peptide (SLP) therapeutic vaccine technology was published by Leiden University Medical Centre (LUMC) in the Journal for ImmunoTherapy for Cancer. It […]

November 8, 2022 - 2 minutesmins - By Liza Laws

News and Trends 8 Nov 2022

MedinCell’s partner AIC registers trial for drug for total knee replacement pain

A partner of MedinCell, Arthritis Innovation Corporation (AIC), has registered a phase 3 trial to look into an alternative drug to deal with pain after total knee replacement (TKR). Arthritis Innovation Corporation conducts and finances all development activities of the drug F14, or mdc-CWM, being trialed. It was registered with the safety and efficacy study […]

November 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Nov 2022

AI program yields multiple novel RSV drug targets

Poolbeg Pharma says it has made a breakthrough in its Artificial Intelligence (AI) program with partner OneThree Biotech, Inc. through the discovery of novel drug targets for the treatment of respiratory syncytial virus (RSV). Following the completion of the build and optimization of a tailored AI model in June 2022, the OneThree team, using its […]

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

The Peter MacCallum Cancer Centre (Peter Mac) and Cartherics Pty Ltd (Cartherics) have entered into a collaborative development program agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the treatment of cutaneous T-cell lymphoma (CTCL). “Patients with advanced stages of cutaneous T-cell lymphomas often have few treatment options left when their disease […]

November 8, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Better Juice launches naturally converting fruit juice sugars to prebiotics

Wyss Center’s ABILITY system to improve quality of life for people with severe paralysis

Sensorium closes $30M deal to advance drug discovery engine

GHO Capital and Vistria Group to acquire CDMO Alcami

Does covid vaccination boost cancer treatment?

Google and Meta AI could boost cancer research and drug discovery

JelloX Biotech helps doctors diagnose and treat cancer tumors with speed and accuracy

Vir Biotech presents new data for functional cure of chronic Hep B virus

ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy

MedinCell’s partner AIC registers trial for drug for total knee replacement pain

AI program yields multiple novel RSV drug targets

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!